Johns Hopkins researchers say that a computerized checklist system dramatically reduced the number of dangerous venous thromboembolisms (VTEs) in hospitalized patients. The system is designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients.
When a doctor enters medical orders for such patients, the automated checklist recommends evidence-based best treatments for each patient's needs, usually the regular administration of low-dose blood thinners or the use of compression devices to keep blood flowing in the legs. The researchers say this new system worked far better than previous methods, which included handing out laminated cards outlining best practices or lectures presented on the topic of preventing VTE, a term that covers dangerous clots in the legs and lungs.
The research team found a nearly two-fold improvement in prophylaxis orders among patients who had no contraindications to receiving the low-dose blood thinners. Blood thinners are often not ordered in patients with bleeding risk, as they can exacerbate bleeding.
"VTE hits all segments of the population," says Elliott R. Haut, M.D., an associate professor of surgery at the Johns Hopkins University School of Medicine, and leader of the study described in the October issue of Archives of Surgery. "All hospitalized patients are at risk for this complication, and a huge number of these deadly clots are preventable if we give patients the right prophylaxis. We tried education alone for years and still only 40 to 60 percent of patients were getting optimal treatment. With this computerized system, we have made great strides toward making sure every patient gets exactly what he or she needs."
More than 600,000 people get a VTE each year in the United States and one in six die as a result, more than the number who die annually from breast cancer, AIDS or in car crashes. In 2008, the U.S. Surgeon General made a call to action to prevent DVT and PE.
The Agency for Healthcare Research and Quality (AHRQ) has called appropriate prophylaxis the number one patient safety initiative needed to prevent in-hospital death.
As part of the study, Johns Hopkins computer programmers added a checklist for appropriate VTE prophylaxis to the hospital's computerized health records system. After information is input about the patient''s case, the computer suggests appropriate treatment for prevention. Doctors can still override the system if they choose.
Before the checklist was put in place in January, 2008, records show that physicians at The Johns Hopkins Hospital offered the best prophylaxis to two-thirds of trauma patients, the researchers say. During the four-year implementation of the program, they found, 85 percent of the 1,599 trauma patients in the study received appropriate prophylaxis.
"It's a huge jump in doing right for patients," Haut says, but the goal is 100 percent.
Trauma patients are at a particularly high risk of developing DVT or PE, as risk factors for VTE include major surgery and extreme injury, especially to the spinal cord.
Haut says that many hospitals - including Johns Hopkins - have in recent years been giving nearly all of their patients some sort of prophylaxis for dangerous blood clots. But the problem, he says, is that patients don''t always get as much treatment as they need and, in many cases, evidence-based best practices are not being followed.
Many hospitals say they give nearly all of their patients some type of VTE prophylaxis and that is true Haut says, but they often fail to give all that is necessary to prevent blood clots.
"The computerized tool makes ordering the right thing really easy," says Haut, a trauma surgeon on the core faculty of the Johns Hopkins Armstrong Institute for Patient Safety.
Haut says he understands that not every hospital has electronic health records up and running, but says the expense of adding the VTE checklist to existing electronic systems is minimal now that Hopkins has designed the program.
Other Johns Hopkins researchers involved in the study include Bradyn D. Lau, M.P.H.; Franca S. Kraenzlin, M.H.S.; Deborah B. Hobson, B.S.N.; Peggy S. Kraus, PharmD; Howard T. Carolan, M.P.H., M.B.A.; Adil H. Haider, M.D., M.P.H.; Christine G. Holzmueller, B.L.A.; David T. Efron, M.D.; Peter J. Pronovost, M.D., Ph.D.; and Michael B. Streiff, M.D.
For more information: